NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Conditions:   Coronary Artery Disease;   Percutaneous Coronary Intervention;   Acute Coronary Syndrome Interventions:   Drug: Aspirin + Clopidogrel + Rivaroxaban;   Drug: Aspirin + Clopidogrel Sponsor:   China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials